CV Sciences, Inc. (CVSI)
| Previous Close | 0.0535 |
| Open | 0.0531 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0453 - 0.0580 |
| 52 Week Range | 0.0300 - 0.0600 |
| Volume | |
| Avg. Volume | 269,883 |
| Market Cap | 7.998M |
| Beta (5Y Monthly) | 0.55 |
| PE Ratio (TTM) | 2.45 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2024, before the stock market opens on Tuesday, May 14, 2024. The Company will hold a conference call with the investment community at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time) tha
- PR Newswire
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2023.
- PR Newswire
CV Sciences, Inc. Expands +PlusCBD Pet Product Offerings with the Launch of Pet Chews
CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, proudly announces its latest innovation and product launch: a premier CBD chew tailored for pets, +PlusCBD™ Pet Hip and Joint Health Chews and +PlusCBD™ Pet Calming Care Chews. +PlusCBD™Pet wellness treats are crafted with the utmost care and supported by extensive research, and
